Brian Van Tine, ASCO20: Summary of the Phase 1 SPEARHEAD-1 Trial in Sarcoma

Spearhead 1 StudyПодробнее

SPEARHEAD-1: afamitresgene autoleucel in advanced synovial sarcomaПодробнее

Updates in Sarcoma: 2023 West OncologyПодробнее

OsteoBites S2 Ep6: Brian Van Tine, MD, PhD on “Osteosarcoma Tumor Metabolism”Подробнее

Dr. Van Tine on Collaboration and Clinical Trials in Uterine SarcomaПодробнее

Brian Van Tine, MD, considers the role of real-world outcomes in the treatment of sarcomaПодробнее

E. Norry & D. Williams present initial data from SPEARHEAD-1 trialПодробнее

Brian Van Tine, MD, discusses the design of the SPEARHEAD-1 trialПодробнее

Dr. Van Tine on Next Steps With ADP-A2M4 in Advanced Solid TumorsПодробнее

Brian Van Tine, MD, on the most promising investigational agents in advanced sarcomaПодробнее

Brian Van Tine, MD, PhDПодробнее

SPEARHEAD-1: afamitresgene autoleucel in advanced synovial and myxoid liposarcomaПодробнее

Afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoi...Подробнее

Brian Van Tine, ESMO 2019 - Pazopanib in soft tissue sarcomasПодробнее

ASCO 2013 - Brian Van Tine M.D., PH.D., Molecular ProfilingПодробнее

Hot topics in sarcoma at ASCO 2021Подробнее

APROMISS: catequentinib in synovial sarcomaПодробнее

SPEARHEAD-1: ADP-A2M4 in synovial sarcoma and MRCLSПодробнее

Toronto Cardiac Tumor Conference 2020 Brian Van TineПодробнее